SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-09-000867
Filing Date
2009-02-17
Accepted
2009-02-17 09:52:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 KERYX BIOPHARMACEUTICALS, INC. p09-0165sc13ga.txt SC 13G/A 94132
  Complete submission text file 0000902664-09-000867.txt   96314
Mailing Address 885 THIRD AVENUE NEW YORK NY 10022
Business Address 885 THIRD AVENUE NEW YORK NY 10022 2124464020
DAVIDSON KEMPNER PARTNERS (Filed by) CIK: 0000928549 (see all company filings)

IRS No.: 133393346
Type: SC 13G/A

Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78786 | Film No.: 09607658
SIC: 2834 Pharmaceutical Preparations